IP Library Granted Patent US 10,166,035
Granted Patent B2
US 10,166,035 · App. 15/062,979 · Granted Jan 1, 2019

Endovascular devices and methods for exploiting intramural space

Inventors: Chad J. Kugler (Buffalo, MN); Matthew J. Olson (Grafton, ND); Robert E. Atkinson (Lake Elmo, MN)
Assignee: BRIDGEPOINT MEDICAL, INC.
A61B17/22A61B17/221A61B17/22031A61B17/32037A61B17/3417A61F2/88A61M25/0194A61M25/104A61B17/00008A61B2017/003A61B2017/00252A61B2017/22034A61B2017/22095A61B2017/320044A61B2017/320741A61M25/0032A61M25/0045A61M25/0069A61M25/0152A61M2025/006A61M2025/0197
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,166,035
App. No.
15/062,979
Granted
Jan 1, 2019
Kind
B2
Abstract

Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.

Claims (28)

1. A method of bypassing an occlusion disposed in a lumen of a vessel having a vascular wall, the method comprising:

inserting a distal end of an elongate shaft of an intravascular device into the lumen proximal of the occlusion;

entering the vascular wall of the vessel with the distal end of the elongate shaft of the intravascular device at a location proximal of the occlusion;

advancing the distal end of the elongate shaft between first and second tissue layers of the vascular wall to a location distal of the occlusion;

advancing a re-entry device through the elongate shaft of the intravascular device, the re-entry device having a tissue penetrating distal tip;

penetrating the first tissue layer of the vascular wall with the tissue penetrating distal tip of the re-entry device such that the tissue-penetrating distal tip enters the lumen of the vessel distal of the occlusion; and

thereafter, advancing the distal end of the elongate shaft of the intravascular device from the vascular wall into the lumen of the vessel distal of the occlusion such that the elongate shaft of the intravascular device extends from the lumen of the vessel proximal of the occlusion, through a subintimal space between the first and second tissue layers along the occlusion, to the lumen of the vessel distal of the occlusion.

2. The method of claim 1 , further comprising rotationally orienting the elongate shaft of the intravascular device in the subintimal space after advancing the distal end of the elongate shaft between the first and second tissue layers of the vascular wall to the location distal of the occlusion.

3. The method of claim 1 , wherein the elongate shaft of the intravascular device includes a concave side.

4. The method of claim 3 , further comprising rotationally orienting the concave side of the elongate shaft of the intravascular device toward the first tissue layer after advancing the distal end of the elongate shaft between the first and second tissue layers of the vascular wall to the location distal of the occlusion.

5. The method of claim 1 , wherein the elongate shaft of the intravascular device includes a deployable element.

6. The method of claim 5 , wherein the deployable element is expandable from a collapsed configuration to a deployed configuration.

7. The method of claim 6 , wherein the deployable element is constrained within an actuatable sheath while in the collapsed configuration.

8. The method of claim 7 , wherein the actuatable sheath is retracted from the deployable element to permit the deployable element to expand to the deployed configuration.

9. The method of claim 5 , further comprising:

expanding the deployable element in first and second opposite directions between the first and second tissue layers.

10. The method of claim 5 , wherein the deployable element is an expandable lattice structure.

11. The method of claim 10 , wherein the expandable lattice structure is formed of nickel titanium.

12. The method of claim 1 , further comprising:

advancing a guidewire through the elongate shaft of the intravascular device into the lumen distal of the occlusion.

13. The method of claim 12 , wherein the guidewire is advanced through the elongate shaft of the intravascular device into the lumen distal of the occlusion with the distal end of the elongate shaft of the intravascular device positioned in the lumen distal of the occlusion.

14. The method of claim 13 , further comprising:

retaining the guidewire in the lumen distal of the occlusion while withdrawing the elongate shaft of the intravascular device from the vessel.

15. The method of claim 14 , further comprising:

advancing an angioplasty balloon catheter over the guidewire into the subintimal space after withdrawing the elongate shaft of the intravascular device.

16. The method of claim 15 , further comprising dilating the subintimal space with the angioplasty balloon catheter.

17. The method of claim 14 , further comprising:

stenting the subintimal space after withdrawing the elongate shaft of the intravascular device.

Assignments (1)
NUNC PRO TUNC ASSIGNMENT Recorded Mar 22, 2022
From: BRIDGEPOINT MEDICAL, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 059512/0160 →
Continuity (8)
Continuation 13948646 · Jul 23, 2013
Continuation 13304157 · Nov 23, 2011
Continuation 11518429 · Sep 11, 2006
Provisional Application 60811478 · Jun 7, 2006
Provisional Application 60727819 · Oct 18, 2005
Provisional Application 60717726 · Sep 15, 2005
Provisional Application 60716287 · Sep 12, 2005
Related Publication 20160183953A1 · Jun 30, 2016
Cited By (3)
US 12,251,128 US 12,303,652 US 12,539,389